Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23592522)

  • 1. p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity.
    Tornillo G; Elia AR; Castellano I; Spadaro M; Bernabei P; Bisaro B; Camacho-Leal Mdel P; Pincini A; Provero P; Sapino A; Turco E; Defilippi P; Cabodi S
    Stem Cells; 2013 Jul; 31(7):1422-33. PubMed ID: 23592522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
    Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit.
    Smart CE; Wronski A; French JD; Edwards SL; Asselin-Labat ML; Waddell N; Peters K; Brewster BL; Brooks K; Simpson K; Manning N; Lakhani SR; Grimmond S; Lindeman GJ; Visvader JE; Brown MA
    Oncogene; 2011 Mar; 30(13):1597-607. PubMed ID: 21132007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
    Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p130Cas is an essential transducer element in ErbB2 transformation.
    Cabodi S; Tinnirello A; Bisaro B; Tornillo G; del Pilar Camacho-Leal M; Forni G; Cojoca R; Iezzi M; Amici A; Montani M; Eva A; Di Stefano P; Muthuswamy SK; Tarone G; Turco E; Defilippi P
    FASEB J; 2010 Oct; 24(10):3796-808. PubMed ID: 20505116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.
    Zhao Y; Kumbrink J; Lin BT; Bouton AH; Yang S; Toselli PA; Kirsch KH
    Carcinogenesis; 2013 Dec; 34(12):2880-90. PubMed ID: 23825155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
    Gardner HP; Ha SI; Reynolds C; Chodosh LA
    Cancer Res; 2000 Oct; 60(19):5571-7. PubMed ID: 11034105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
    Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S
    Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
    Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling.
    Chiche A; Di-Cicco A; Sesma-Sanz L; Bresson L; de la Grange P; Glukhova MA; Faraldo MM; Deugnier MA
    Breast Cancer Res; 2019 Jan; 21(1):13. PubMed ID: 30683141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway.
    Kaenel P; Antonijevic M; Richter S; Küchler S; Sutter N; Wotzkow C; Strange R; Andres AC
    Int J Oncol; 2012 Feb; 40(2):357-69. PubMed ID: 22020958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.
    Iglesias JM; Cairney CJ; Ferrier RK; McDonald L; Soady K; Kendrick H; Pringle MA; Morgan RO; Martin F; Smalley MJ; Blyth K; Stein T
    PLoS One; 2015; 10(3):e0119718. PubMed ID: 25803307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGF.
    Camacho Leal Mdel P; Pincini A; Tornillo G; Fiorito E; Bisaro B; Di Luca E; Turco E; Defilippi P; Cabodi S
    PLoS One; 2012; 7(12):e49817. PubMed ID: 23239970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stemness in Wnt-driven mammary tumorigenesis.
    Monteiro J; Gaspar C; Richer W; Franken PF; Sacchetti A; Joosten R; Idali A; Brandao J; Decraene C; Fodde R
    Carcinogenesis; 2014 Jan; 35(1):2-13. PubMed ID: 23955540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
    Pellegrini P; Cordero A; Gallego MI; Dougall WC; Muñoz P; Pujana MA; Gonzalez-Suarez E
    Stem Cells; 2013 Sep; 31(9):1954-65. PubMed ID: 23766243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.